Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Pharmacological stimulation of brain carnitine palmitoyl-transferase-1 decreases food intake and body weight.

Aja S, Landree LE, Kleman AM, Medghalchi SM, Vadlamudi A, McFadden JM, Aplasca A, Hyun J, Plummer E, Daniels K, Kemm M, Townsend CA, Thupari JN, Kuhajda FP, Moran TH, Ronnett GV.

Am J Physiol Regul Integr Comp Physiol. 2008 Feb;294(2):R352-61. Epub 2007 Dec 5.

2.

Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.

Zhou W, Han WF, Landree LE, Thupari JN, Pinn ML, Bililign T, Kim EK, Vadlamudi A, Medghalchi SM, El Meskini R, Ronnett GV, Townsend CA, Kuhajda FP.

Cancer Res. 2007 Apr 1;67(7):2964-71.

3.

Application of a flexible synthesis of (5R)-thiolactomycin to develop new inhibitors of type I fatty acid synthase.

McFadden JM, Medghalchi SM, Thupari JN, Pinn ML, Vadlamudi A, Miller KI, Kuhajda FP, Townsend CA.

J Med Chem. 2005 Feb 24;48(4):946-61.

PMID:
15715465
4.

C75 alters central and peripheral gene expression to reduce food intake and increase energy expenditure.

Tu Y, Thupari JN, Kim EK, Pinn ML, Moran TH, Ronnett GV, Kuhajda FP.

Endocrinology. 2005 Jan;146(1):486-93. Epub 2004 Oct 21.

PMID:
15498887
5.

Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass.

Thupari JN, Kim EK, Moran TH, Ronnett GV, Kuhajda FP.

Am J Physiol Endocrinol Metab. 2004 Jul;287(1):E97-E104. Epub 2004 Jan 21.

6.

C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism.

Landree LE, Hanlon AL, Strong DW, Rumbaugh G, Miller IM, Thupari JN, Connolly EC, Huganir RL, Richardson C, Witters LA, Kuhajda FP, Ronnett GV.

J Biol Chem. 2004 Jan 30;279(5):3817-27. Epub 2003 Nov 13.

7.

C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity.

Thupari JN, Landree LE, Ronnett GV, Kuhajda FP.

Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9498-502. Epub 2002 Jun 11.

8.

Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.

Thupari JN, Pinn ML, Kuhajda FP.

Biochem Biophys Res Commun. 2001 Jul 13;285(2):217-23. Erratum in: Biochem Biophys Res Commun 2002 Jul 12;295(2):570.

PMID:
11444828
9.
10.

Thyroglobulin-reactive T lymphocytes in thyroiditis-prone BB/Wor rats.

Allen EM, Thupari JN.

J Endocrinol Invest. 1995 Jan;18(1):45-9.

PMID:
7759784
11.

Autoantibody formation in burn patients after inhibition of suppressor T cell activity with polymyxin B.

Moran KT, Anholt GT, O'Reilly TJ, Thupari JN, Munster AM.

J Burn Care Rehabil. 1989 May-Jun;10(3):213-5.

PMID:
2545721
12.

Effect of immunoglobulin G therapy on serum antibody titers to cytomegalovirus in burn patients.

Moran KT, Thupari JN, O'Reilly TJ, Munster AM.

Am J Surg. 1988 Feb;155(2):294-7.

PMID:
2829640
13.

Depressed natural killer cell function in thermally injured adults: successful in vivo and in vitro immunomodulation and the role of endotoxin.

Bender BS, Winchurch RA, Thupari JN, Proust JJ, Adler WH, Munster AM.

Clin Exp Immunol. 1988 Jan;71(1):120-5.

14.

Endotoxemia in burn patients: levels of circulating endotoxins are related to burn size.

Winchurch RA, Thupari JN, Munster AM.

Surgery. 1987 Nov;102(5):808-12.

PMID:
3672321
15.

Reversal of postburn immunosuppression with low-dose polymyxin B.

Munster AM, Winchurch RA, Thupari JN, Ernst CB.

J Trauma. 1986 Nov;26(11):995-8.

PMID:
2878088
16.

Lightning injury: physics, pathophysiology and clinical features.

Moran KT, Thupari JN, Munster AM.

Ir Med J. 1986 May;79(5):120-2. No abstract available.

PMID:
3721823
17.

Electric- and lightning-induced cardiac arrest reversed by cardiopulmonary resuscitation.

Moran KT, Thupari JN, Munster AM.

JAMA. 1986 Apr 25;255(16):2157. No abstract available.

PMID:
3959295

Supplemental Content

Loading ...
Support Center